SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-010337
Filing Date
2024-02-05
Accepted
2024-02-05 06:40:33
Documents
17
Period of Report
2024-02-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm245182d1_8k.htm   iXBRL 8-K 34565
2 EXHIBIT 2.1 tm245182d1_ex2-1.htm EX-2.1 862921
3 EXHIBIT 99.1 tm245182d1_ex99-1.htm EX-99.1 16308
7 GRAPHIC tm245182d1_ex99-1img01.jpg GRAPHIC 4317
  Complete submission text file 0001104659-24-010337.txt   1274679

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA elan-20240205.xsd EX-101.SCH 3067
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE elan-20240205_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elan-20240205_pre.xml EX-101.PRE 22355
18 EXTRACTED XBRL INSTANCE DOCUMENT tm245182d1_8k_htm.xml XML 3493
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

IRS No.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 24593898
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)